Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project

NCT01964209 | Completed DMC

• 1 other identifier: 83064
• Study Type: observational
• Target: 48
• Locations: 1 country
• Sites: 1

Brief Summary

This proposal is to evaluate the reliability and validity of the Vanderbilt ADHD screening tool for use with adolescents and young adults aged 13-21 years. The Vanderbilt is a previously developed, freely available set of parent- and teacher-report questionnaires designed to identify ADHD and related disorders in children. The Vanderbilt measures have been chosen for inclusion in the new computerized Integrated Clinical Information Sharing System (ICISS) being rolled out in five Boston Children's Hospital (BCH) departments/divisions (Adolescent/Young Adult Practice, Children's Hospital Primary Care Center, Developmental Medicine Center, Department of Neurology, Department of Psychiatry). The Vanderbilt was developed and validated for use among children up to age 12 years (Wolraich et al., 2003; Wolraich et al., 2013; Bard et al., 2013), and little is known about its appropriateness for use among older youth. In addition, there is no self-report version of the Vanderbilt that can be administered directly to adolescents and young adults (ages 13-21 years), for whom parents and teachers are often less knowledgeable reporters. To address these shortcomings, a multidisciplinary team of BCH adolescent health clinicians and researchers modified the parent and teacher Vanderbilt questionnaires to make them age-appropriate for adolescents and young adults and created a complementary self-report version for adolescents and young adults. The goal of the current study is to 1) assess the feasibility and acceptability of online administration through the ICISS system of the new parent, teacher, and youth self-report Vanderbilt measures among adolescent and young adult BCH patients aged 13-21 years; 2) test their reliability in terms of internal consistency reliability, temporal stability of responses over a one-month test-retest, and inter-rater agreement across all informants (parents, teachers, and youths); and 3) test their validity by evaluating their convergence with a similar set of ADHD screening tools, the Conners scales, already validated for use with adolescents and young adults.

Conditions

ADHD

Keywords

ADHD; Validation; Quality Improvement; Vanderbilt; Conners 3rd Edition; ADHD Measures; ADHD Adolescent; ADHD Questionnaire; ICISS; Integrated Clinical Information Sharing System

Outcome Measures

Primary Outcomes (1)

• Reliability of the Vanderbilt

  We will assess for each measure the level of internal consistency reliability, temporal stability of responses over a one-month test-retest, and inter-rater agreement across all informants (parents, teachers, and youths).

  One month after initial administration of Vanderbilt

Secondary Outcomes (1)

• Validity of Vanderbilt

  One month after initial administration of Conners

Study Arms (1)

No treatment

This is a psychometric study of a screening tool for ADHD, so we will not be administering any treatments or interventions.

Eligibility Criteria

• Age: 13 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Boston Children's Hospital patients which will be recruited from the following divisions: Adolescent/Young Adult Practice, Developmental Medicine Center and Department of Psychiatry.

You may qualify if:

• Patients ages 13-21 who already have an ADHD diagnosis or are being evaluated for ADHD.
• Parent/guardian will be asked to participate for patients ages 13-21.
• Teachers will be asked to participate for patients ages 13-21.
• All informants should be able to read and understand English at a 5th grade reading level; and enrolled in the ICISS system.

You may not qualify if:

• Cognitive impairment or developmental delay.

Sponsors & Collaborators

• Boston Children's Hospital: lead

Study Sites (1)

Boston Children's Hospital, Adolescent/ Young Adult Clinic

Boston, Massachusetts, 02115, United States

Location

Related Publications (11)

• Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, Mrazek DA, Jacobsen SJ. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002 Mar;156(3):217-24. doi: 10.1001/archpedi.156.3.217.

  PMID: 11876664 BACKGROUND

• Bard DE, Wolraich ML, Neas B, Doffing M, Beck L. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr. 2013 Feb;34(2):72-82. doi: 10.1097/DBP.0b013e31827a3a22.

  PMID: 23363972 BACKGROUND

• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul;4(7):28-37.

  PMID: 20526405 BACKGROUND

• Conners CK, Wells KC, Parker JD, Sitarenios G, Diamond JM, Powell JW. A new self-report scale for assessment of adolescent psychopathology: factor structure, reliability, validity, and diagnostic sensitivity. J Abnorm Child Psychol. 1997 Dec;25(6):487-97. doi: 10.1023/a:1022637815797.

  PMID: 9468109 BACKGROUND

• Erhardt, D., Epstein, J. N., Conners, C. K., Parker, J. D., Sitarenios, G. (1999, October). Self-ratings of ADHD symptoms in adults II: reliability, validity, and diagnostic sensitivity. Journal of Attention Disorders, 3 (3), 153-158

  BACKGROUND

• Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844.

  PMID: 15520087 BACKGROUND

• Matza LS, Johnston JA, Faries DE, Malley KG, Brod M. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res. 2007 Nov;16(9):1511-20. doi: 10.1007/s11136-007-9254-9. Epub 2007 Sep 12.

  PMID: 17874207 BACKGROUND

• Van Voorhees EE, Hardy KK, Kollins SH. Reliability and validity of self- and other-ratings of symptoms of ADHD in adults. J Atten Disord. 2011 Apr;15(3):224-34. doi: 10.1177/1087054709356163. Epub 2010 Apr 27.

  PMID: 20424007 BACKGROUND

• Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007 Jan 3;5:2. doi: 10.1186/1477-7525-5-2.

  PMID: 17201923 BACKGROUND

• Wolraich ML, Bard DE, Neas B, Doffing M, Beck L. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population. J Dev Behav Pediatr. 2013 Feb;34(2):83-93. doi: 10.1097/DBP.0b013e31827d55c3.

  PMID: 23363973 BACKGROUND

• Wolraich ML, Lambert W, Doffing MA, Bickman L, Simmons T, Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003 Dec;28(8):559-67. doi: 10.1093/jpepsy/jsg046.

  PMID: 14602846 BACKGROUND

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders

Study Officials

• Joshua Borus, MD,MPH

  Boston Children's Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Staff Physician

Study Record Dates

• First Submitted: October 10, 2013
• First Posted: October 17, 2013
• Study Start: May 1, 2014
• Primary Completion: July 1, 2018
• Study Completion: November 15, 2018
• Last Updated: January 17, 2023

Record last verified: 2023-01

Locations

US (1)